More on NCI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.5 Score)
- Holders
- Dividends (1.7% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (12/31/19 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

NCI Cash Flow Statement

Click line-items for a historical chart and %
Net income 44.59M
Depreciation expense 20.55M
Amortization expense 8.72M
Share-based compensation expense 9.45M
Accretion of interest expense 526K
Deferred income taxes 625K
Allowance for doubtful accounts receivable 7.01M
Accounts receivable -63.92M
Prepaid expenses and other assets 5.32M
Accounts payable 959K
Accrued liabilities 1.08M
Accrued compensation-related costs 296K
Income taxes payable 16.94M
Other liabilities 1.61M
Net cash used in operating activities
Purchases of property and equipment -13.46M
Acquisitions of businesses, net of cash acquired -8M
Payments of acquisition liabilities -5.5M
Other investing, net
Net cash used in investing activities
Issuances of common stock 3.57M
Payment upon termination of credit agreement
Proceeds from new credit agreement
Borrowings from banks, net of repayments
Payments of term loan
Payments of Debt Issuance Costs
Other, net -2.8M
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents -157K
Net decrease in cash and cash equivalents -1.85M
Cash and cash equivalents at beginning of the period 8.9M
Cash and cash equivalents at end of the period 7.04M